Repligen (RGEN) Current Assets (2011 - 2026)
Repligen's (RGEN) quarterly Current Assets came in at $1.2 billion in Q2 2026, up 13.6% year-over-year from $1.1 billion in Q2 2025, and up 3.37% quarter-over-quarter from $1.2 billion in Q1 2026.
Analysis
Repligen (RGEN) Current Assets (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Current Assets for 16 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Assets rose 13.6% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 13.6% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 6.69% from the prior year.
- Current Assets was $1.2 billion for Q2 2026 at Repligen, up from $1.2 billion in the prior quarter.
- Over five years, Current Assets peaked at $1.2 billion in Q2 2026 and troughed at $944.8 million in Q1 2022.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Current Assets.
- Across the five-year window, Current Assets climbed 15.68% in 2024 and dropped 8.72% in 2025, its largest moves.
- Over 5 years, Current Assets stood at $998.1 million in 2022, then grew by 11.34% to $1.1 billion in 2023, then dropped by 4.08% to $1.1 billion in 2024, then advanced by 6.69% to $1.1 billion in 2025, then grew by 5.55% to $1.2 billion in 2026.
- The last three Current Assets figures came in at $1.2 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 23.37 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 13.38 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 4.69 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 2.83 Bn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 2.30 Bn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 744.40 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 3.02 Bn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 1.20 Bn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 674.67 Mn |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | 2.23 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Bn |
| Mar 31, 2026 | 1.16 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.10 Bn |
| Jun 30, 2025 | 1.06 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | 1.13 Bn |
| Dec 31, 2023 | 1.11 Bn |
| Sep 30, 2023 | 980.47 Mn |
| Jun 30, 2023 | 999.93 Mn |
| Mar 31, 2023 | 1.02 Bn |
| Dec 31, 2022 | 998.12 Mn |
| Sep 30, 2022 | 953.23 Mn |
| Jun 30, 2022 | 976.00 Mn |
| Mar 31, 2022 | 944.79 Mn |
| Dec 31, 2021 | 931.68 Mn |
| Sep 30, 2021 | 910.85 Mn |